@article{d19b1b6ff11c40da8d80669f62c7789b,
title = "インターロイキン-23阻害剤はFibrosis-4 indexが上昇した乾癬患者においてFibrosis-4 indexを低下させるがインターロイキン-17阻害剤は低下させない(Interleukin-23 inhibitors decrease Fibrosis-4 index in psoriasis patients with elevated Fibrosis-4 index but not inteleukin-17 inhibitors)",
keywords = "*乾癬(合併症,薬物療法), *モノクローナル抗体(治療的利用), 分散分析, *肝線維症(合併症), Secukinumab(治療的利用), Brodalumab(治療的利用), Ixekizumab(治療的利用), Guselkumab(治療的利用), Risankizumab(治療的利用), ヒト, 成人(19～44), 中年(45～64), 男, 女",
author = "Takeshima Ryosuke and Kamata Masahiro and Suzuki Shoya and Ito Makoto and Watanabe Ayu and Uchida Hideaki and Chijiwa Chika and Okada Yoshiki and Azuma Saori and Nagata Mayumi and Egawa Shota and Hiura Azusa and Fukaya Saki and Hayashi Kotaro and Fukuyasu Atsuko and Tanaka Takamitsu and Ishikawa Takeko and Tada Yayoi",
year = "2024",
month = sep,
doi = "10.1111/1346-8138.17277",
language = "American English",
volume = "51",
pages = "1216--1224",
journal = "Journal of Dermatology",
issn = "0385-2407",
publisher = "John Wiley and Sons Inc",
number = "9",
}